Yayıncı "BIOMED CENTRAL LTD" için listeleme
Toplam kayıt 2, listelenen: 1-2
-
Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
(BIOMED CENTRAL LTD, 2018)Background: Worldwide, over 10 million individuals suffer from drug-resistant epilepsy. New therapeutic strategies are needed to address this debilitating disease. Inhibition of sodium-glucose linked transporters (SGLTs), ... -
Serum micro-rna profiles in patients with autosomal dominant polycystic kidney disease according to hypertension and renal function
(BIOMED CENTRAL LTD, 2017)Background: Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary disorder with unclear disease mechanism. Currently, overt hypertension and increased renal volume are the best predictors of renal ...